NASDAQ
3.16USD
+0.03 (+0.96%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
52M
P/E
—
EPS
—
Beta
1.12
52W range
2.66-5.49
Day range
3.02–3.34
Open
3.17
Prev close
3.13
Volume
54K
Avg volume
49.1K
Dividend
0.00
IPO
2016-07-26
https://www.marketbeat.com/instant-alerts/sensus-healthcare-q2-earnings-call-highlights-2026-08-13/ · 8/14/2026-0.40
https://www.defenseworld.net/2026/01/18/sensus-healthcare-nasdaqsrts-vs-envoy-medical-nasdaqcoch-financial-contrast.html · 1/18/2026+0.00
https://www.businesswire.com/news/home/20260107668649/en/Sensus-Healthcare-to-Hold-Investor-Meetings-During-JPM-Week-2026-in-San-Francisco/ · 1/7/2026+0.10
https://seekingalpha.com/article/4839930-sensus-healthcare-inc-srts-q3-2025-earnings-call-transcript · 11/7/2025+0.00
https://www.businesswire.com/news/home/20251031424413/en/Sensus-Healthcare-Announces-the-Passing-of-Director-Bill-McCall/ · 10/31/2025-0.20
https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sensus-healthcare-inc---srts-302567908.html · 9/28/2025-1.00
https://www.globenewswire.com/news-release/2025/09/24/3155624/1087/en/INVESTOR-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Sensus-Healthcare-Inc-SRTS.html · 9/24/2025-1.00
https://www.globenewswire.com/news-release/2025/08/31/3141913/0/en/SENSUS-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-Sensus-Healthcare-Inc-on-Behalf-of-Sensus-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html · 8/31/2025-1.00
https://www.businesswire.com/news/home/20250824561702/en/SRTS-Investors-Have-Opportunity-to-Join-Sensus-Healthcare-Inc.-Fraud-Investigation-with-the-Schall-Law-Firm/ · 8/24/2025-1.00
https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sensus-healthcare-inc---srts-302535472.html · 8/22/2025-1.00
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works